Revised PPO to boost domestic medical device manufacturing in line with 'Make in India' Revised PPO to boost domestic medical device manufacturing in line with 'Make in India' 05 April 2021 | News This comes as a great relief to the 85 per cent import dependence forced upon India and an ever increasing import bill of over Rs 42000 crore Source credit: Shutterstock The revised notice issued by The Department of Pharmaceuticals (DoP) on the Public Procurement Order (PPO) on March 25, 2021, where they have incorporated 19 medical devices in the revised guidelines of the PPO will boost domestic medical device manufacturing by strengthening ‘Make in India’ and is estimated to reduce imports bill by approx Rs 4000 crore. This comes as a great relief to the 85 per cent import dependence forced upon India and an ever-increasing import bill of over Rs 42000 crore.